Listed

Vsee Health, Inc.

VSEECIK 1864531HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.6mRevenue, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 14, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.6mRevenue, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure+48.0% on a year earlier
  • Gross margin13.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $206.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure−45.1 pts on a year earlier
  • Operating margin−172.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure−25.2 pts on a year earlier
  • Net margin−111.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure+136.0 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow−$1.2mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Capital expenditure: $73.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Report this figure−270.6% on a year earlier

Last eight quarters

Full statements
Revenue$1.6mGross margin 13.2%
Diluted EPS−$0.05, Q1 FY2026
Free cash flow−$1.2m, Q2 FY2026
Vsee Health, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k3,354Revenue, Q3 FY2024, three months to 2024-09-30$3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure3,734Revenue, Q4 FY2024, three months to 2024-12-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure3,321Revenue, Q1 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure1,055Revenue, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure3,981Revenue, Q3 FY2025, three months to 2025-09-30$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure3,926Revenue, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure3,160Revenue, Q1 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure1,562Revenue, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure
Gross margin%83.0%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure63.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $2.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure56.0%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $1.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure58.3%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $615.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure52.1%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure46.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $1.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure37.9%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $1.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure13.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $206.2k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure
Operating margin%(1737.8%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$58.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure(81.1%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(55.1%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(147.5%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure(51.7%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure(87.6%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(94.1%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(172.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure
Net margin%(1607.5%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$53.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure(85.9%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(119.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(247.7%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q/A filed 2025-11-20, accession 0001185185-25-001818.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure(7.3%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$289.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Revenue: $4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figure(200.0%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(82.3%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Revenue: $3.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(111.7%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Revenue: $1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-14, accession 0001185185-26-003549.Report this figure
Diluted EPS$ per share(3.58)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figurenot reported (Diluted EPS not reported)(0.24)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(0.16)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2025-11-20, accession 0001185185-25-001818.Report this figure(0.02)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001185185-25-001744.Report this figurenot reported (Diluted EPS not reported)(0.05)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$k(226)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$221.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001185185-25-001744. Derived: 9-month figure less the 6-month figure.Capital expenditure: $5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001185185-25-001744. Derived: 9-month figure less the 6-month figure.Report this figure(2,979)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(452)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$440.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Capital expenditure: $11.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(336)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$324.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Capital expenditure: −$11.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Report this figure(777)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$754.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001185185-25-001744. Derived: 9-month figure less the 6-month figure.Capital expenditure: $22.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001185185-25-001744. Derived: 9-month figure less the 6-month figure.Report this figure(1,933)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Capital expenditure: $7.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001185185-26-001202. Derived: 12-month figure less the 9-month figure.Report this figure(2,479)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Capital expenditure: $26.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001185185-26-001883.Report this figure(1,247)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Capital expenditure: $73.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001185185-26-003549. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$14.6mGross margin 50.3%
Diluted EPS−$0.73, FY2025
Free cash flow−$3.5m, FY2025
Vsee Health, Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$mnot reported (Revenue not reported)5.8Revenue, FY2023, twelve months to 2023-12-31$5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure10.4Revenue, FY2024, twelve months to 2024-12-31$10.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure14.6Revenue, FY2025, twelve months to 2025-12-31$14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure
Gross margin%not reported (Gross profit and Revenue not reported)66.5%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $3.8m. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure68.9%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $7.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $10.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure50.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $7.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure
Operating margin%not reported (Revenue not reported)(32.5%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure(596.4%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$62.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $10.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure(65.6%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure
Net margin%not reported (Revenue not reported)(65.3%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Revenue: $5.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure(553.7%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$57.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $10.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure(100.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001185185-26-001202.Revenue: $14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure
Diluted EPS$ per share(0.25)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-04-12, accession 0001104659-24-046607.Report this figure(0.38)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure(5.65)Diluted EPS, FY2024, twelve months to 2024-12-31−$5.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure(0.73)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)(0.6)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$632.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Capital expenditure: $4.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-08-29, accession 0001558370-25-011815.Report this figure(5.8)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001185185-26-001202.Capital expenditure: $55.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure(3.5)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001185185-26-001202.Capital expenditure: $29.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001185185-26-001202.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Vsee Health, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Linden Advisors LP2026-06-30$17.2k500,000Unchanged
MMCAP International Inc. SPC2026-06-30$15.2k500,000Unchanged
D. E. Shaw & Co., Inc.2026-06-30$11.7k365,000Unchanged
BOOTHBAY FUND MANAGEMENT, LLC2026-06-30$10.1k87,179Unchanged
Clear Street Group Inc.2026-06-30$9.7k320,203Unchanged
Alberta Investment Management Corp2026-06-30$7.6k250,000Unchanged
Saba Capital Management, L.P.2026-06-30$7.4k243,249Unchanged
WHITEBOX ADVISORS LLC2026-06-30$7.0k232,500Unchanged
Quad-Cities Investment Group, LLC2026-06-30$3.7k121,000Unchanged
StoneX Group Inc.2026-06-30$3.2k97,275Added+64,850

Recent filings

All 288 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Vsee Health, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-0121:29 ETS-1Registration statement0001185185-26-004518
2026-09-3020:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-26-004440
2026-09-2320:10 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001185185-26-004244
2026-09-0920:10 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-26-003896
2026-08-3120:10 ET8-K5.02 Departure or appointment of officers or directors0001185185-26-003768
2026-08-2620:10 ET8-K5.07 Shareholder vote results0001185185-26-003729
2026-08-1420:12 ET10-QQuarterly reportPeriod 2026-06-300001185185-26-003549
2026-08-0421:20 ET8-K3.01 Delisting notice0001185185-26-003262
2026-07-3120:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-26-003211
2026-07-2420:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001185185-26-003124

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 31, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1864531
Tickers
VSEE, VSEED, VSEEW
Exchange
not reported
SIC code
8000 Services-Health Services
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Former names
DIGITAL HEALTH ACQUISITION CORP. (to 2024-06-12)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.